These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 4132990)
1. An inhibitor of histamine release from human leukocytes. Kelly MT; White A J Clin Invest; 1974 May; 53(5):1343-50. PubMed ID: 4132990 [TBL] [Abstract][Full Text] [Related]
2. Histamine release induced by human leukocyte lysates. Reabsorption of previously released histamine after exposure to cyclic amp-active agents. Kelly MT; White A J Clin Invest; 1973 Aug; 52(8):1834-40. PubMed ID: 4124206 [TBL] [Abstract][Full Text] [Related]
3. Mediators of histamine release from human platelets, lymphocytes, and granulocytes. Kelly MT; Martin RR; White A J Clin Invest; 1971 May; 50(5):1044-9. PubMed ID: 4101589 [TBL] [Abstract][Full Text] [Related]
4. Histamine release in the dog after leukocyte lysate injection. Kelly MT; Brashear RE; Martin RR; White A Infect Immun; 1971 Sep; 4(3):228-31. PubMed ID: 4117288 [TBL] [Abstract][Full Text] [Related]
5. Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors. White MV; Kaplan AP; Haak-Frendscho M; Kaliner M J Immunol; 1988 Nov; 141(10):3575-83. PubMed ID: 2460539 [TBL] [Abstract][Full Text] [Related]
6. Histamine release induced by human leukocyte lysates: effect of metabolic inhibitors and carbohydrates. Kelly MT; White A Infect Immun; 1973 Jul; 8(1):15-8. PubMed ID: 4124153 [TBL] [Abstract][Full Text] [Related]
7. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. Liu MC; Proud D; Lichtenstein LM; MacGlashan DW; Schleimer RP; Adkinson NF; Kagey-Sobotka A; Schulman ES; Plaut M J Immunol; 1986 Apr; 136(7):2588-95. PubMed ID: 2419444 [TBL] [Abstract][Full Text] [Related]
8. Histamine release induced by himan leukocyte lysates: implication of a specific, complement-independent, noncytotoxic reaction. Kelly MT; White A Infect Immun; 1973 Jul; 8(1):8-14. PubMed ID: 4124155 [TBL] [Abstract][Full Text] [Related]
9. Enhancement by a serum factor of immunoglobulin-mediated histamine release from human leukocytes. Petersson BA; Stålenheim G Int Arch Allergy Appl Immunol; 1977; 55(1-6):178-88. PubMed ID: 73507 [TBL] [Abstract][Full Text] [Related]
10. Complement-induced histamine release from human basophils. I. Generation of activity in human serum. Hook WA; Siraganian RP; Wahl SM J Immunol; 1975 Apr; 114(4):1185-90. PubMed ID: 46892 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of reagin-mediated PCA reactions in monkeys and histamine release from human leukocytes by human IgG4 subclass. Vijay HM; Perelmutter L Int Arch Allergy Appl Immunol; 1977; 53(1):78-87. PubMed ID: 65338 [TBL] [Abstract][Full Text] [Related]
13. Regulation by serine esterase of histamine release from human leukocytes--I. Direct release of histamine by the serine esterase inhibitors diisopropyl fluorophosphate (DFP) and soman (GD). Meier HL; Gross CL; Papirmeister B Biochem Pharmacol; 1986 Dec; 35(23):4125-30. PubMed ID: 2431690 [TBL] [Abstract][Full Text] [Related]
14. Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes. Luben RA; Mundy GR; Trummel CL; Raisz LG J Clin Invest; 1974 May; 53(5):1473-80. PubMed ID: 4825237 [TBL] [Abstract][Full Text] [Related]
15. The diisopropylfluorophosphate inhibitable step in antigen-induced histamine release from human leukocytes. Pruzansky JJ; Patterson R J Immunol; 1975 Mar; 114(3):939-43. PubMed ID: 46264 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of IgE-mediated histamine release from human leukocytes by a new xanthine derivative, D 4026. Petersson BA; Svedinger I; Bohlinder K Agents Actions; 1980 Nov; 10(5):403-10. PubMed ID: 6163338 [TBL] [Abstract][Full Text] [Related]
17. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-8 and RANTES inhibit basophil histamine release induced with monocyte chemotactic and activating factor/monocyte chemoattractant peptide-1 and histamine releasing factor. Alam R; Forsythe PA; Lett-Brown MA; Grant JA Am J Respir Cell Mol Biol; 1992 Oct; 7(4):427-33. PubMed ID: 1382479 [TBL] [Abstract][Full Text] [Related]
19. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. MacDonald SM; Lichtenstein LM; Proud D; Plaut M; Naclerio RM; MacGlashan DW; Kagey-Sobotka A J Immunol; 1987 Jul; 139(2):506-12. PubMed ID: 2439589 [TBL] [Abstract][Full Text] [Related]
20. IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3. Kuna P; Reddigari SR; Kornfeld D; Kaplan AP J Immunol; 1991 Sep; 147(6):1920-4. PubMed ID: 1716285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]